NEW YORK, NY / ACCESS Newswire / June 16, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/zenas-biopharma-inc-lawsuit-submission-form?prid=153291&wire=1&utm_campaign=27 or contact Joseph E. Levi, Esq.

image for news Securities Fraud Class Action Filed Against Zenas BioPharma, Inc. (ZBIO) - Levi & Korsinsky Reminds Investors of June 16, 2025

Recent US-China trade truce talks have left unresolved the critical issue of export restrictions on specialized rare earth materials essential for American military hardware, according to a Reuters report. Beijing is yet to commit to exporting certain rare earth magnets needed by US suppliers for fighter jets and missile systems, sources told the publication.

image for news China holds back rare earths as it pushes for AI chip access in trade talks: report

Executive Orders Build Momentum for Higher Uranium Prices — Positive

URNJ  URNM   ETF Trends — June 16, 2025

President Trump's executive orders on May 23 continue to build momentum for uranium. That's because investors are more clear on the direction the administration will take in terms of using nuclear power.

image for news Executive Orders Build Momentum for Higher Uranium Prices

5 Large Drug Stocks That Are Poised to Ride on Sector Recovery — Neutral

ABBV  BAYRY  NVS  PFE  SNY   Zacks Investment Research — June 16, 2025

In the Large-Cap Pharmaceuticals industry, AbbVie, Novartis, Pfizer, Sanofi and Bayer are worth retaining amid macro pressure and rising innovation.

image for news 5 Large Drug Stocks That Are Poised to Ride on Sector Recovery

EOG Resources (EOG) Soars 3.9%: Is Further Upside Left in the Stock? — Positive

EOG   Zacks Investment Research — June 16, 2025

EOG Resources (EOG) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

image for news EOG Resources (EOG) Soars 3.9%: Is Further Upside Left in the Stock?

Under $5 and Down 20% YTD, Is NIO Stock a Bargain Buy Now? — Positive

NIO   Zacks Investment Research — June 16, 2025

NIO Inc. NIO is a notable name in the Chinese EV market with several growth drivers in place. Vehicle deliveries are rising, new models are being rolled out, its battery swap technology gives it an edge, and the company continues to make progress in smart driving and operational efficiency.

image for news Under $5 and Down 20% YTD, Is NIO Stock a Bargain Buy Now?

TOST Stock Rises 19% in Three Months: Time to Hold or Make an Exit? — Positive

TOST   Zacks Investment Research — June 16, 2025

Toast, Inc. TOST shares have gained 19.2% in the past three months, outperforming the Internet Software market and the Zacks Computer & Technology sector's growth of 12.5% and 9.7%, respectively. The S&P 500 Composite has returned 5.3% over the same time frame.

image for news TOST Stock Rises 19% in Three Months: Time to Hold or Make an Exit?

NEW YORK , June 16, 2025 /PRNewswire/ -- Standard Motor Products, Inc. (NYSE: SMP), a leading automotive parts manufacturer and distributor, has been recognized as one of Newsweek's America's Greatest Workplaces 2025 and was also named one of America's Greatest Workplaces in Manufacturing. These lists recognize the greatest workplaces in the United States based on their performance on a range of metrics from the perspective of employees, including corporate culture, working conditions, and other aspects of their current employer and other companies they are familiar with.

image for news Standard Motor Products, Inc. Named One of America's Greatest Workplaces 2025

Intuit: Mailchimp And TurboTax Live Platforms Can Turbocharge Growth — Positive

INTU   Seeking Alpha — June 16, 2025

TurboTax Live is well-positioned to turbocharge Intuit's growth margins, with the US tax software market share size projected to grow at a 10.1% CAGR up to 2030. With an increasing number of small businesses integrating AI, Mailchimp will expand Intuit's customer base significantly and deliver a significant boost to EPS beyond the TurboTax and QuickBooks. Despite being vulnerable to cyclical downturns and reliant on third-party vendors, Intuit has a strong balance sheet, excellent growth potential, and an attractive valuation, making this a golden buying opportunity.

image for news Intuit: Mailchimp And TurboTax Live Platforms Can Turbocharge Growth

NORTHVILLE, Mich., June 16, 2025 (GLOBE NEWSWIRE) -- Tenneco's Clevite Elastomers business, a leading global supplier of components that help minimize noise, vibration and harshness (NVH) encountered in the operation of passenger vehicles, commercial trucks, buses, and other transportation applications, has joined a research consortium exploring opportunities to establish domestic production of natural rubber using agricultural products. Funded through a grant from the U.S. National Science Foundation (NSF) and led by The Ohio State University, the Transformation of American Rubber through Domestic Innovation for Supply Security (TARDISS) project aims to reduce U.S. manufacturers' reliance on rubber imports, protecting the nation's …

image for news Tenneco's Clevite Elastomers Business Joins Consortium Exploring Use of U.S. Crops in Production of Natural Rubber

Buy 4 Discretionary Stocks With Upside as Inflation Continues to Cool — Positive

CCL  FOX  NFLX  TILE   Zacks Investment Research — June 16, 2025

Cooling inflation, easing trade tensions, and rate cut hopes lift outlook for discretionary stocks like NFLX and FOX.

image for news Buy 4 Discretionary Stocks With Upside as Inflation Continues to Cool

Deckers Bets on Brand Momentum: Can HOKA & UGG Keep Up the Growth? — Positive

DECK   Zacks Investment Research — June 16, 2025

DECK rides strong global demand as HOKA and UGG post solid growth and expand reach with new products and innovations.

image for news Deckers Bets on Brand Momentum: Can HOKA & UGG Keep Up the Growth?

McDonald's Settles $10B Lawsuit: Should You Buy Now or Hold Steady? — Neutral

MCD   Zacks Investment Research — June 16, 2025

MCD is advancing its value platform, tech innovation and category expansion amid ongoing macroeconomic headwinds.

image for news McDonald's Settles $10B Lawsuit: Should You Buy Now or Hold Steady?

NEW YORK, NY / ACCESS Newswire / June 16, 2025 / If you suffered a loss on your Fortrea Holdings Inc. (NASDAQ:FTRE) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fortrea-holdings-inc-lawsuit-submission-form?prid=153251&wire=1&utm_campaign=12 or contact Joseph E. Levi, Esq.

image for news Lost Money on Fortrea Holdings Inc. (FTRE)? Contact Levi & Korsinsky Before August 1, 2025 to Join Class Action

NEW YORK, NY / ACCESS Newswire / June 16, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=153285&wire=1&utm_campaign=10 or contact Joseph E. Levi, Esq.

image for news Contact Levi & Korsinsky by July 7, 2025 to Join Class Action Against West Pharmaceutical Services, Inc. (WST)

Acuity Brands: There's Potential, Just Not Right Now — Positive

AYI   Seeking Alpha — June 16, 2025

Acuity Brands (AYI) has shown steady revenue per share and margin growth, with improving return on invested capital since the pandemic. Dividend growth has been minimal but is finally picking up, supported by a very low payout ratio, suggesting room for future increases. Recent Q2 2025 earnings showed strong Non-GAAP EPS growth but a revenue miss, indicating mixed short-term performance.

image for news Acuity Brands: There's Potential, Just Not Right Now

Is Trump targeting the NHS in trade negotiations? This reports says it is — Negative

AZN   Proactive Investors — June 16, 2025

Britain could face higher drug costs as part of a deal to stave off future tariffs from Donald Trump, according to a report in the Daily Telegraph. Documents released after a recent trade agreement show the NHS is expected to review its approach to drug pricing in response to US demands.

image for news Is Trump targeting the NHS in trade negotiations? This reports says it is

Crude Oil Price Outlook – Crude Gives Back Initial Gains on Monday — Negative

BNO  DBO  GUSH  IEO  OIH  OIL  PXJ  UCO  USO  XOP   FXEmpire — June 16, 2025

The crude oil market initially gapped higher on Monday, only to turn back around and show signs of weakness. In fact, by the time we got to the “open cry” session, the market had turned negative.

image for news Crude Oil Price Outlook – Crude Gives Back Initial Gains on Monday

Digital Realty Stock Rallies 14.9% in 3 Months: Will This Continue? — Positive

DLR   Zacks Investment Research — June 16, 2025

DLR shares rise 14.9% in three months, powered by global expansion, leasing gains and rising demand for AI-driven data centers.

image for news Digital Realty Stock Rallies 14.9% in 3 Months: Will This Continue?

Can J&J's Innovative Medicines Unit Sustain Growth Amid Stelara LOE? — Positive

JNJ   Zacks Investment Research — June 16, 2025

JNJ's Innovative Medicines unit shows a growth trend, defying Stelara LOE and the negative impact of the Part D redesign.

image for news Can J&J's Innovative Medicines Unit Sustain Growth Amid Stelara LOE?